Complications of antiretroviral therapy initiation in hospitalised patients with HIV-associated tuberculosis.
HIV-associated tuberculosis is a common coinfection in Sub-Saharan Africa, which causes high morbidity and mortality. A sub-set of HIV-associated tuberculosis patients require prolonged hospital admission, during which antiretroviral therapy initiation may be required. The aim of this study was to d...
Main Authors: | Helen van der Plas, Graeme Meintjes, Charlotte Schutz, Rene Goliath, Landon Myer, Dorothea Baatjie, Robert J Wilkinson, Gary Maartens, Marc Mendelson |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2013-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3568128?pdf=render |
Similar Items
-
Rifampicin resistance and mortality in patients hospitalised with HIV-associated tuberculosis
by: Ruan Spies, et al.
Published: (2022-09-01) -
Clofazimine for the treatment of tuberculosis
by: Jacob A. M. Stadler, et al.
Published: (2023-02-01) -
AntiRetroviral Therapy In Second-line: investigating Tenofovir-lamivudine-dolutegravir (ARTIST): protocol for a randomised controlled trial [version 1; peer review: 2 approved, 1 approved with reservations]
by: Zimasa Gcwabe, et al.
Published: (2021-02-01) -
Prognostic indicators in the World Health Organization’s algorithm for seriously ill HIV-infected inpatients with suspected tuberculosis
by: Rulan Griesel, et al.
Published: (2018-02-01) -
Case report: Emergence of dolutegravir resistance in a patient on second-line antiretroviral therapy
by: Kairoonisha Mahomed, et al.
Published: (2020-07-01)